Deciphering Adverse Drug Reactions: In Vitro Priming and Characterization of Vancomycin-Specific T Cells From Healthy Donors Expressing HLA-A*32:01
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Deciphering Adverse Drug Reactions: In Vitro Priming and Characterization of Vancomycin-Specific T Cells From Healthy Donors Expressing HLA-A*32:01
Authors
Keywords
-
Journal
TOXICOLOGICAL SCIENCES
Volume 183, Issue 1, Pages 139-153
Publisher
Oxford University Press (OUP)
Online
2021-06-25
DOI
10.1093/toxsci/kfab084
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cross-reactivity between vancomycin, teicoplanin and telavancin in HLA-A*32:01 positive vancomycin DRESS patients sharing an HLA-Class II haplotype
- (2020) Nontaya Nakkam et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Development of an Improved T-cell Assay to Assess the Intrinsic Immunogenicity of Haptenic Compounds
- (2020) Monday O Ogese et al. TOXICOLOGICAL SCIENCES
- HLA-A*32:01 is strongly associated with vancomycin-induced drug reaction with eosinophilia and systemic symptoms
- (2019) Katherine C. Konvinse et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- A Rapid Allele-Specific Assay for HLA-A*32:01 to Identify Patients at Risk for Vancomycin-Induced Drug Reaction with Eosinophilia and Systemic Symptoms
- (2019) Francois X. Rwandamuriye et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- CXCR3 enables recruitment and site-specific bystander activation of memory CD8+ T cells
- (2019) Nicholas J. Maurice et al. Nature Communications
- Genetic and nongenetic factors that may predispose individuals to allergic drug reactions
- (2018) Andrew Gibson et al. Current Opinion in Allergy and Clinical Immunology
- Developments in Glycopeptide Antibiotics
- (2018) Mark A. T. Blaskovich et al. ACS Infectious Diseases
- Immune-mediated reactions to vancomycin
- (2016) Jasmit S. Minhas et al. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
- Clinical pharmacology considerations in biologics development
- (2012) Liang Zhao et al. ACTA PHARMACOLOGICA SINICA
- Abacavir induces loading of novel self-peptides into HLA-B*57
- (2012) Michael A. Norcross et al. AIDS
- Human leukocyte antigen (HLA)-B*57:01-restricted activation of drug-specific T cells provides the immunological basis for flucloxacillin-induced liver injury
- (2012) Manal M. Monshi et al. HEPATOLOGY
- Immune self-reactivity triggered by drug-modified HLA-peptide repertoire
- (2012) Patricia T. Illing et al. NATURE
- Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire
- (2012) D. A. Ostrov et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- In silico analysis of HLA associations with drug-induced liver injury: use of a HLA-genotyped DNA archive from healthy volunteers
- (2012) Ana Alfirevic et al. Genome Medicine
- CXCR3 in T cell function
- (2011) Joanna R. Groom et al. EXPERIMENTAL CELL RESEARCH
- High risk of cross-reactivity between vancomycin and sequential teicoplanin therapy
- (2011) S.-H. Hsiao et al. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS
- Fulminant Liver Failure After Vancomycin in a Sulfasalazine-Induced DRESS Syndrome: Fatal Recurrence After Liver Transplantation
- (2009) M. Mennicke et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Human memory CCR4+CD8+ T cell subset has the ability to produce multiple cytokines
- (2009) T. Kondo et al. INTERNATIONAL IMMUNOLOGY
- Human Leukocyte Antigen Class I-Restricted Activation of CD8+ T Cells Provides the Immunogenetic Basis of a Systemic Drug Hypersensitivity
- (2008) Diana Chessman et al. IMMUNITY
- HLA-B*5701 Screening for Hypersensitivity to Abacavir
- (2008) Simon Mallal et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now